New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat

Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication of a new clinical study in US medical journal, Obesity Pillars, demonstrating Calocurb’s effectiveness in weight loss and muscle preservation. In the brand’s fourth human clinical study users saw an average weight loss of 8.3 lbs (3.77 kg) after […]